Saturday, April 20, 2019
Home Tags Cancer

Tag: cancer

Galectin Therapeutics, Inc. (NASDAQ: GALT) A Potential $10 Billion Buyout

Miami, FL - September 12, 2018 7:55 PM (EmergingGrowth.com NewsWire) -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of...

Galectin Therapeutics (NASDAQ: GALT) Drops Phase 3 Cancer Bombshell at HC...

Miami, FL - September 7, 2018 (EmergingGrowth.com NewsWire) -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

CytoDyn, Inc. (OTCQB: CYDY) Disruptive Targeting of HIV and Expands Indications...

Miami, FL - August 13, 2018 (EmergingGrowth.com NewsWire) -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) Gains 8.84% After Announcing Two Scheduled...

PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) is a specialty pharmaceutical company, which develops treatments to treat cancer in dogs and pets. Shares of the pet...

Tyme Technologies, Inc. (OTCQB: TYMI) Surges 48.15% After Approval To Uplist...

Tyme Technologies, Inc. (OTCQB: TYMI) operates as a biotechnology company, which specifically develops cancer therapeutic treatments. Shares of the biotechnology company are skyrocketing 48.15%,...

Sunshine Biopharma, Inc. (OTC Pink: SBFM) Surges 144.57% After Releasing Results...

Sunshine Biopharma, Inc. (OTC Pink: SBFM) is engaged within the research, development, and commercialization of cancer treatment drugs. Shares of the cancer treatment company...

Q BioMed, Inc. (OTCQB: QBIO) Increases 13.37% After Commercialization of Non-Narcotic...

Q BioMed, Inc. (OTCQB: QBIO) is engaged within the acquisition, development, licensing, and commercialization of biomedical assets. Shares of the biomedical acceleration and development...

Northwest Biotherapeutics, Inc. (OTCQB: NWBO) Declines 14.29% After 8-K Details of...

Northwest Biotherapeutics, Inc. (OTCQB: NWBO) is engaged within the research, development, and commercialization of immunotherapy treatments to help treat cancer and other immune system...

Advanced Medical Isotope Corp. (OTC Pink: ADMD) Rallies 10% After Providing...

Advanced Medical Isotope Corp. (OTC Pink: ADMD) is engaged within the research, production, and distribution of medical isotopes. Shares of the medical company are...

Propanc Biopharma, Inc. (OTCQB: PPCHD) Rallies 27% After Awaiting FDA Orphan...

Propanc Biopharma, Inc. (OTCQB: PPCHD) is an Australian-based biopharmaceutical company, which focuses on developing cancer treatments. Shares of the cancer biotech company are rallying...